Xiaofeng Chen

1.9k total citations
63 papers, 1.2k citations indexed

About

Xiaofeng Chen is a scholar working on Oncology, Surgery and Molecular Biology. According to data from OpenAlex, Xiaofeng Chen has authored 63 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Oncology, 20 papers in Surgery and 17 papers in Molecular Biology. Recurrent topics in Xiaofeng Chen's work include Cancer Immunotherapy and Biomarkers (11 papers), Cancer Cells and Metastasis (8 papers) and Esophageal Cancer Research and Treatment (7 papers). Xiaofeng Chen is often cited by papers focused on Cancer Immunotherapy and Biomarkers (11 papers), Cancer Cells and Metastasis (8 papers) and Esophageal Cancer Research and Treatment (7 papers). Xiaofeng Chen collaborates with scholars based in China, United States and Malaysia. Xiaofeng Chen's co-authors include Huijun Zhang, Dayu Huang, Mingchuan Zhao, Qinyun Ma, Hongtao Zhang, Jiucun Wang, Shicheng Guo, Wenyong Zhou, Lei Zhang and Jun Zhu and has published in prestigious journals such as SHILAP Revista de lepidopterología, Experimental Cell Research and Molecular Cancer.

In The Last Decade

Xiaofeng Chen

60 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaofeng Chen China 19 558 409 260 226 210 63 1.2k
Moo Jun Baek South Korea 20 532 1.0× 492 1.2× 245 0.9× 196 0.9× 147 0.7× 87 1.3k
Yi‐Wei Xu China 20 480 0.9× 269 0.7× 225 0.9× 218 1.0× 352 1.7× 97 1.2k
Thanh H. Dellinger United States 22 542 1.0× 424 1.0× 233 0.9× 112 0.5× 203 1.0× 77 1.3k
Peter Mu‐Hsin Chang Taiwan 23 631 1.1× 466 1.1× 209 0.8× 211 0.9× 224 1.1× 54 1.3k
Xingsheng Yang China 27 800 1.4× 409 1.0× 412 1.6× 160 0.7× 202 1.0× 95 1.8k
Bohao Zheng China 19 422 0.8× 520 1.3× 333 1.3× 241 1.1× 248 1.2× 53 1.3k
Yun Hong China 22 693 1.2× 522 1.3× 330 1.3× 351 1.6× 115 0.5× 76 1.6k
Haoran Li China 14 491 0.9× 336 0.8× 345 1.3× 187 0.8× 169 0.8× 81 1.1k
Qiyun Tang China 23 625 1.1× 282 0.7× 366 1.4× 168 0.7× 179 0.9× 65 1.3k

Countries citing papers authored by Xiaofeng Chen

Since Specialization
Citations

This map shows the geographic impact of Xiaofeng Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaofeng Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaofeng Chen more than expected).

Fields of papers citing papers by Xiaofeng Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaofeng Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaofeng Chen. The network helps show where Xiaofeng Chen may publish in the future.

Co-authorship network of co-authors of Xiaofeng Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaofeng Chen. A scholar is included among the top collaborators of Xiaofeng Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaofeng Chen. Xiaofeng Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hu, Jingjuan, Fan Deng, Qi‐Shun Sun, et al.. (2025). Time-restricted feeding protects against septic liver injury by reshaping gut microbiota and metabolite 3-hydroxybutyrate. Gut Microbes. 17(1). 2486515–2486515. 1 indexed citations
2.
Zhang, Zhixiong, Wei Xie, Qiang Huang, et al.. (2025). Discovery of STING antagonists targeting cGAS-STING pathway to alleviate IMQ-induced psoriasis-like dermatitis. European Journal of Pharmaceutical Sciences. 210. 107091–107091. 1 indexed citations
3.
Chen, Xiaofeng, et al.. (2025). Navigating challenges in hydrocephalus following intraventricular hemorrhage: a comprehensive review of current evidence. Frontiers in Neurology. 16. 1630286–1630286.
4.
5.
Wang, An, et al.. (2024). The carcinogenesis of esophageal squamous cell cancer is positively regulated by USP13 through WISP1 deubiquitination. BioFactors. 51(1). e2139–e2139. 1 indexed citations
6.
Wu, Ning, et al.. (2024). Rad51 and Systemic Inflammatory Indicators as Novel Prognostic Markers in Esophageal Squamous Cell Carcinoma. Technology in Cancer Research & Treatment. 23. 2223958221–2223958221. 1 indexed citations
7.
Lin, Jun-Peng, Xiaofeng Chen, Peiyuan Wang, et al.. (2024). Conditional Survival of Patients with Limited-Stage Small Cell Lung Cancer After Surgery: A National Real-World Cohort Study. Annals of Surgical Oncology. 31(7). 4250–4260. 2 indexed citations
8.
Wu, Peijie, Yueqiang Wen, Chao Liu, et al.. (2023). The zhuyu pill relieves rat cholestasis by regulating the mRNA expression of lipid and bile metabolism associated genes. Frontiers in Pharmacology. 14. 1280864–1280864. 4 indexed citations
9.
10.
11.
Wang, Peiyuan, Feng Wang, Hao He, et al.. (2021). TP53 and CDKN2A mutations in patients with early-stage lung squamous cell carcinoma: an analysis of the correlations and prognostic outcomes. Annals of Translational Medicine. 9(16). 1330–1330. 15 indexed citations
12.
13.
Ma, Qinyun, Dayu Huang, Huijun Zhang, et al.. (2016). Function of follicular helper T cell is impaired and correlates with survival time in non-small cell lung cancer. International Immunopharmacology. 41. 1–7. 41 indexed citations
14.
Huang, Dayu, et al.. (2016). Thymosin beta 4 silencing suppresses proliferation and invasion of non-small cell lung cancer cells by repressing Notch1 activation. Acta Biochimica et Biophysica Sinica. 48(9). 788–794. 15 indexed citations
15.
Qian, Yingying, Qian Wu, Xiaofeng Chen, et al.. (2014). The ERCC1 C118T Polymorphism Predicts Clinical Outcomes of Colorectal Cancer Patients Receiving Oxaliplatin-Based Chemotherapy: a Meta-analysis Based on 22 Studies. Asian Pacific Journal of Cancer Prevention. 15(19). 8383–8390. 16 indexed citations
16.
Zhao, Mingchuan, Yishi Zhang, Huijun Zhang, et al.. (2014). Hypoxia-induced cell stemness leads to drug resistance and poor prognosis in lung adenocarcinoma. Lung Cancer. 87(2). 98–106. 55 indexed citations
17.
Chen, Jun, Rengyun Liu, Lixin Yang, et al.. (2012). A two-SNP IL-6 promoter haplotype is associated with increased lung cancer risk. Journal of Cancer Research and Clinical Oncology. 139(2). 231–242. 29 indexed citations
18.
Zhang, Huijun, Heyong Wang, Hongtao Zhang, et al.. (2011). Transforming growth factor-β1 promotes lung adenocarcinoma invasion and metastasis by epithelial-to-mesenchymal transition. Molecular and Cellular Biochemistry. 355(1-2). 309–314. 71 indexed citations
19.
Chen, Xiaofeng, Huijun Zhang, Haibing Wang, et al.. (2011). Transforming growth factor-β1 induces epithelial-to-mesenchymal transition in human lung cancer cells via PI3K/Akt and MEK/Erk1/2 signaling pathways. Molecular Biology Reports. 39(4). 3549–3556. 111 indexed citations
20.
Chen, Xiaofeng. (2009). The research progress of epithelial-mesenchymal transition in tumor invasion and metastasis. Shengming kexue. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Moo Jun Baek Breakdown of academic impact, for papers by Yi‐Wei Xu Breakdown of academic impact, for papers by Thanh H. Dellinger Breakdown of academic impact, for papers by Peter Mu‐Hsin Chang Breakdown of academic impact, for papers by Xingsheng Yang Breakdown of academic impact, for papers by Bohao Zheng Breakdown of academic impact, for papers by Yun Hong Breakdown of academic impact, for papers by Haoran Li Breakdown of academic impact, for papers by Qiyun Tang
Rankless by CCL
2026